Glucocorticoids paradoxically facilitate steroid resistance in T-cell acute lymphoblastic leukemias and thymocytes.

Glucocorticoids (GCs) are a central component of therapy for patients with T-cell acute lymphoblastic leukemia (T-ALL) and while resistance to GCs is a strong negative prognostic indicator in T-ALL, mechanisms of GC resistance remain poorly understood. Using diagnostic samples from patients enrolled on the frontline Children's Oncology Group (COG) T-ALL clinical trial AALL1231, we demonstrated that one-third of primary T-ALLs were resistant to GCs when cultured in the presence of interleukin-7 (IL7), a cytokine that is critical for normal T-cell function and that plays a well-established role in leukemogenesis. We demonstrated that in these T-ALLs and in distinct populations of normal developing thymocytes, GCs paradoxically induced their own resistance by promoting upregulation of IL7 receptor (IL7R) expression. In the presence of IL7, this augmented downstream signal transduction resulting in increased STAT5 transcriptional output and upregulation of the pro-survival protein BCL-2. Taken together, we demonstrated that IL7 mediates an intrinsic and physiologic mechanism of GC resistance in normal thymocyte development that is retained during leukemogenesis in a subset of T-ALLs and is reversible with targeted inhibition of the IL7R/JAK/STAT5/BCL-2 axis.

[1]  W.-J. Liu,et al.  Prognostic value of the response to prednisone for children with acute lymphoblastic leukemia: a meta-analysis. , 2018, European review for medical and pharmacological sciences.

[2]  R. van Boxtel,et al.  STAT5 is essential for IL-7-mediated viability, growth, and proliferation of T-cell acute lymphoblastic leukemia cells. , 2018, Blood advances.

[3]  T. Hara,et al.  Glucocorticoids Drive Diurnal Oscillations in T Cell Distribution and Responses by Inducing Interleukin‐7 Receptor and CXCR4 , 2018, Immunity.

[4]  Cheng Cheng,et al.  THE GENOMIC LANDSCAPE OF PEDIATRIC AND YOUNG ADULT T-LINEAGE ACUTE LYMPHOBLASTIC LEUKEMIA , 2017, Nature Genetics.

[5]  M. Loh,et al.  Suppression of B-cell development genes is key to glucocorticoid efficacy in treatment of acute lymphoblastic leukemia. , 2017, Blood.

[6]  J. Taunton,et al.  JAK/STAT pathway inhibition overcomes IL7-induced glucocorticoid resistance in a subset of human T-cell acute lymphoblastic leukemias , 2017, Leukemia.

[7]  Paul Flicek,et al.  The international Genome sample resource (IGSR): A worldwide collection of genome variation incorporating the 1000 Genomes Project data , 2016, Nucleic Acids Res..

[8]  Meagan E. Sullender,et al.  Optimized sgRNA design to maximize activity and minimize off-target effects of CRISPR-Cas9 , 2015, Nature Biotechnology.

[9]  James Y. Zou.  Analysis of protein-coding genetic variation in 60,706 humans , 2015, Nature.

[10]  T. Hara,et al.  An Enhancer of the IL-7 Receptor α-Chain Locus Controls IL-7 Receptor Expression and Maintenance of Peripheral T Cells , 2015, The Journal of Immunology.

[11]  Jennifer A. Doudna,et al.  Generation of knock-in primary human T cells using Cas9 ribonucleoproteins , 2015, Proceedings of the National Academy of Sciences.

[12]  D. Beck,et al.  Opposing regulation of BIM and BCL2 controls glucocorticoid-induced apoptosis of pediatric acute lymphoblastic leukemia cells. , 2015, Blood.

[13]  B. van Steensel,et al.  Easy quantitative assessment of genome editing by sequence trace decomposition , 2014, Nucleic acids research.

[14]  F. Michor,et al.  Evolution of acquired resistance to anti-cancer therapy. , 2014, Journal of theoretical biology.

[15]  N. Socci,et al.  Synthetic lethality in ATM-deficient RAD50-mutant tumors underlies outlier response to cancer therapy. , 2014, Cancer discovery.

[16]  C. Mullighan,et al.  Interleukin-7 receptor mutants initiate early T cell precursor leukemia in murine thymocyte progenitors with multipotent potential , 2014, The Journal of experimental medicine.

[17]  Lanju Zhang,et al.  A New Bliss Independence Model to Analyze Drug Combination Data , 2014, Journal of biomolecular screening.

[18]  Michael P. Snyder,et al.  Identification of STAT5A and STAT5B Target Genes in Human T Cells , 2014, PloS one.

[19]  Christof Fellmann,et al.  An optimized microRNA backbone for effective single-copy RNAi. , 2013, Cell reports.

[20]  A. Letai,et al.  BH3 profiling in whole cells by fluorimeter or FACS. , 2013, Methods.

[21]  C. Pui,et al.  Relapsed childhood acute lymphoblastic leukaemia. , 2013, The Lancet. Oncology.

[22]  A. Sivachenko,et al.  Sensitive detection of somatic point mutations in impure and heterogeneous cancer samples , 2013, Nature Biotechnology.

[23]  C. Sander,et al.  Genome Sequencing Identifies a Basis for Everolimus Sensitivity , 2012, Science.

[24]  B. Meissner,et al.  Prediction of outcome by early bone marrow response in childhood acute lymphoblastic leukemia treated in the ALL-BFM 95 trial: differential effects in precursor B-cell and T-cell leukemia , 2012, Haematologica.

[25]  J. Akey.  Analysis of 2,440 human exomes highlights the evolution and functional impact of rare coding variation , 2011, Genome Biology.

[26]  J. Demengeot,et al.  IL-7 contributes to the progression of human T-cell acute lymphoblastic leukemias. , 2011, Cancer research.

[27]  M. DePristo,et al.  A framework for variation discovery and genotyping using next-generation DNA sequencing data , 2011, Nature Genetics.

[28]  C. Pui,et al.  Biology, risk stratification, and therapy of pediatric acute leukemias: an update. , 2011, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[29]  Helga Thorvaldsdóttir,et al.  Integrative Genomics Viewer , 2011, Nature Biotechnology.

[30]  C. Pui,et al.  Glucocorticoid use in acute lymphoblastic leukaemia. , 2010, The Lancet. Oncology.

[31]  Davis J. McCarthy,et al.  edgeR: a Bioconductor package for differential expression analysis of digital gene expression data , 2009, Bioinform..

[32]  Claudio N. Cavasotto,et al.  Glucocorticoid receptor phosphorylation differentially affects target gene expression. , 2008, Molecular endocrinology.

[33]  R. Mazzucchelli,et al.  Interleukin-7 receptor expression: intelligent design , 2007, Nature Reviews Immunology.

[34]  T. Berki,et al.  Low glucocorticoid receptor (GR), high Dig2 and low Bcl-2 expression in double positive thymocytes of BALB/c mice indicates their endogenous glucocorticoid hormone exposure. , 2006, Immunobiology.

[35]  M. Erlacher,et al.  TCR signaling inhibits glucocorticoid‐induced apoptosis in murine thymocytes depending on the stage of development , 2005, European journal of immunology.

[36]  Pablo Tamayo,et al.  Gene set enrichment analysis: A knowledge-based approach for interpreting genome-wide expression profiles , 2005, Proceedings of the National Academy of Sciences of the United States of America.

[37]  K. Ikuta,et al.  Transcriptional Regulation of the Mouse IL-7 Receptor α Promoter by Glucocorticoid Receptor1 , 2005, The Journal of Immunology.

[38]  Kristina Hanspers,et al.  Gene expression profiles during human CD4+ T cell differentiation. , 2004, International immunology.

[39]  R. Kofler,et al.  Glucocorticoid-induced apoptosis and glucocorticoid resistance: molecular mechanisms and clinical relevance , 2004, Cell Death and Differentiation.

[40]  P. Rothman,et al.  Enhancement of MEK/ERK signaling promotes glucocorticoid resistance in CD4+ T cells , 2004 .

[41]  H. Spits.  Development of αβ T cells in the human thymus , 2002, Nature Reviews Immunology.

[42]  T. Berki,et al.  Glucocorticoid (GC) sensitivity and GC receptor expression differ in thymocyte subpopulations. , 2002, International immunology.

[43]  D. Franchimont,et al.  Positive Effects of Glucocorticoids on T Cell Function by Up-Regulation of IL-7 Receptor α1 , 2002, The Journal of Immunology.

[44]  K. Yamamoto,et al.  Crosstalk pathway for inhibition of glucocorticoid-induced apoptosis by T cell receptor signaling. , 2000, Proceedings of the National Academy of Sciences of the United States of America.

[45]  H. Beug,et al.  Thymocyte apoptosis induced by elevated endogenous corticosterone levels , 1994, European journal of immunology.

[46]  R. Pieters,et al.  Relation of cellular drug resistance to long-term clinical outcome in childhood acute lymphoblastic leukaemia , 1991, The Lancet.

[47]  J. Kakal,et al.  Transcriptional regulation of the IL-7Rα gene by dexamethasone and IL-7 in primary human CD8 T cells , 2016, Immunogenetics.

[48]  P. Rothman,et al.  Enhancement of MEK/ERK signaling promotes glucocorticoid resistance in CD4+ T cells. , 2004, The Journal of clinical investigation.